1130P - Severe oral mucositis (SOM) mitigation by genetically modified lactococcus lactis bacteria (LLB) producing human trefoil factor 1 (hTFF1; AG013) in patients being treated with concomitant chemoradiation (CRT) for oral and oropharyngeal cancers (OCOPC)
| Autor: | Singh, S. 1, Nuyts, S. 2, Doline, R. 3, Satti, S. 4, Schwartz, M. 5, Thatcher, S. 6, Chen, Y. 7, Katz, S. 8, Garg, M. 9, Wagemans, J. 10, Specenier, P. 11, Wittekindt, C. 12, Lee, L. 13, Reifler, J. 14, Sonis, S. 15, Emanuel, M. 16, Cilli, F. 16, Joslyn, A. 17, Wade, J. 18 |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v458-v459 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|